Enzon Pharmaceuticals Inc
(ENZN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2000 | 06-2000 | 12-1999 | 06-1999 | 12-1998 | |
| Sales | 0 | 17,018 | 0 | 13,158 | 13,158 |
| Cost of Goods | N/A | 4,888 | N/A | 4,310 | 4,310 |
| Gross Profit | 5,140 | 12,129 | 2,970 | 8,848 | 2,760 |
| Operating Expenses | 11,796 | 22,227 | 12,956 | 15,279 | 10,283 |
| Operating Income | -11,796 | -9,210 | -12,956 | -6,121 | -1,125 |
| Interest Expense | 0 | 4 | 0 | 8 | 8 |
| Other Income | 0 | 2,907 | 0 | 1,210 | -3,786 |
| Pre-tax Income | -11,796 | -6,307 | -12,956 | -4,919 | -4,919 |
| Income Tax | -512 | N/A | 0 | N/A | 0 |
| Net Income Continuous | -6,306 | -6,307 | -4,919 | -4,919 | -3,617 |
| Net Income | $11,525 | $-6,307 | $-6,307 | $-4,919 | $-4,919 |
| EPS Basic Total Ops | N/A | -0.17 | N/A | -0.14 | -0.12 |
| EPS Basic Continuous Ops | N/A | -0.17 | N/A | -0.14 | -0.12 |
| EPS Diluted Total Ops | N/A | -0.17 | N/A | -0.14 | -0.12 |
| EPS Diluted Continuous Ops | N/A | -0.17 | N/A | -0.14 | -0.12 |
| EBITDA(a) | $-11,536 | $-8,710 | $-12,716 | $-5,285 | $-565 |